Primary Pleural Squamous Cell Carcinoma, Highly Positive PD-L1, Shows Marked Response to Camrelizumab: A Case Report

Here, we reported the rare case of primary pleural squamous cell carcinoma (PPSCC) in a 71-year-old male patient. After chemo and targeted therapies, the patient showed continuous tumor progression and clinical deterioration. Fortunately, the patient had a high expression level of PD-L1 (80%) in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yao, Gao, Ying, Chen, Hai-Ruo, Liu, Hong, Fu, Xi, Yan, Ran, You, Feng-Ming, Li, Zhuo-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278452/
https://www.ncbi.nlm.nih.gov/pubmed/34290540
http://dx.doi.org/10.1177/11795549211028571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278452/
https://www.ncbi.nlm.nih.gov/pubmed/34290540
http://dx.doi.org/10.1177/11795549211028571

Ejemplares similares